Toleranzia AB (OSTO:TOL) Other Income (Expense) : kr0.34 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Other Income (Expense)?

Toleranzia AB's other income expense for the Toleranzia AB's pretax income for the three months ended in Mar. 2024 was kr0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.34 Mil.

Toleranzia AB Other Income (Expense) Historical Data

The historical data trend for Toleranzia AB's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB Other Income (Expense) Chart

Toleranzia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

-2.35

0.10

0.34

Toleranzia AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-	-	-	0.34	-

Toleranzia AB Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.34 Mil.

Toleranzia AB (OSTO:TOL) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Toleranzia AB (OSTO:TOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26

Website

https://www.toleranzia.com

Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.